Benefits and Safety of Empiric Antibiotic Treatment Active Against KPC-K. pneumoniae in Febrile Neutropenic Patients with Acute Leukemia Who are Colonized with KPC-K. pneumoniae. A 7-Years Retrospective Observational Cohort Study

Benefits and Safety of Empiric Antibiotic Treatment Active Against KPC-K. pneumoniae in Febrile Neutropenic Patients with Acute Leukemia Who are Colonized with KPC-K. pneumoniae. A 7-Years Retrospective Observational Cohort Study

Alessandra Micozzi,1 Clara Minotti,2 Saveria Capria,2 Claudio Cartoni,2 Silvia Maria Trisolini,2 Giovanni Manfredi Assanto,1 Walter Barberi,2 Maria Luisa Moleti,2 Stefania Santilli,3 Maurizio Martelli,1 Giuseppe Gentile1 1Haematology, Department of Translational and Precision Medicine, Sapienza Univ...

Descripción completa

Detalles Bibliográficos
Autores principales: Micozzi A, Minotti C, Capria S, Cartoni C, Trisolini SM, Assanto GM, Barberi W, Moleti ML, Santilli S, Martelli M, Gentile G
Formato: Artículo
Lenguaje:English
Publicado: Dove Medical Press 2023-01-01
Colección:Infection and Drug Resistance
Materias:
ceftazidime-avibactam
colistin
haematological malignancies
kpc-k.pneumoniae-bsi mortality rate
Acceso en línea:https://www.dovepress.com/benefits-and-safety-of-empiric-antibiotic-treatment-active-against-kpc-peer-reviewed-fulltext-article-IDR

Internet

https://www.dovepress.com/benefits-and-safety-of-empiric-antibiotic-treatment-active-against-kpc-peer-reviewed-fulltext-article-IDR

Ejemplares similares